|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Closed tracheal suction systems for prevention of ventilator associated pneumonia显示文摘 | SiemposlI Vardakas K Z Falagas M E | 2008 | Br J Anaesth2008，100，3： | 1 |
| 2 | Current control and treatment of multidrug resistant Acinetobacter baumannii infections显示文摘 | KARAGEORGOPOULOS D E FALAGAS M E | | 0，，12： | 1 |
| 3 | Treatment of Acineto- bacter infeetions显示文摘 | Michalopoulos A Falagas M E | 2010 | Expert Opin Pharmacother2010，11，5： | 1 |
| 4 | Current control and treatment of multidrug-resistant Acinetobacter baumannii infections显示文摘 | Karageorgopoulos D E Falagas M E | 2008 | Lancet Infect Dis2008，8，12： | 1 |
| 5 | Urinary tract infections in patients with urinary diversion 显示文摘 | Falagas M E Vergidis P I | 2005 | Am J Kid Dis2005，46，6： | 1 |
| 6 | Resistance to polymyxins: Mechanisms, frequency and treatment options显示文摘 | Falagas M E Rafailidis P I Matthaiou D K | 2010 | Drug Resist Updat2010，13，45： | 1 |
| 7 | Linezolid for the treatment of adults with bone and joint infections 显示文摘 | FALAGAS M E SIEMPOS I I PAPAGELOPOULOS P J | 2007 | Int J Antimicrob Agents2007，29，3： | 1 |
| 8 | Toxoplasmosis snapshots:Global status of Txoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis显示文摘 | Pappas G Roussos N Falagas M E | 2009 | Int J Parasitol2009，39，12： | 1 |
| 9 | Linezolid versus glycopeptide or beta-lactam for treatment of Gram- positive bacterial infections: meta-analysis of randomised controlled trials显示文摘 | FALAGAS M E SIEMPOS I I VARDAKAS K Z | 2008 | Lancet Infect Dis2008，8，1： | 1 |
| 10 | Frequency, characteristics, and predictors of mierobiologically documented nosoeomial infections after cardiac surgery显示文摘 | Geroulanos S Rosmarakis E S Falagas M E etal | 2006 | Eur J Cardiothorac Surg2006，29，4： | 1 |
| 11 | Current control and treatment of multidrug-resistant Acinetobacter baumannii infections显示文摘 | Karageorgopoulos D E Falagas M E | 2008 | Lancet Infect Dis2008，8，12： | 1 |
| 12 | A- mpicillin/sulbactam:current status in severe bacterial in- fections 显示文摘 | RAFAILIDIS P I IOANNIDOU E N FALAGAS M E | 2007 | Drugs2007，67，13： | 1 |
| 13 | Fosfomycin for the treatment of multidrug - resistant, including ex- tended - spectrum beta - lactamase producing, Enterobacteriaeeae infections : a systematic review 显示文摘 | FALAGAS M E KASTORIS A C KAPASKELIS A M | 2010 | Lancet Infect Dis2010，10，1： | 1 |
| 14 | Antimicrobial suscepti- bility of Gram - positive non - urinary isolates to foslbmycin 显示文摘 | Falagas M E Maraki S Karageorgopoulos DE | 2010 | Int J Antinlierob Agents2010，35，5： | 1 |
| 15 | New antibiotic agents for bloodstream infections显示文摘 | Vergidis P I Falagas M E | 2008 | Int J Antimicrob Agents2008，321，： | 1 |
| 16 | Linezolid versus glycopeptides or beta-lactam for treatment of gram-positive bacterial infections: Meta- analysis of randomized controlled trials显示文摘 | FALAGAS M E SIEMPOS I I VARDAKAS K Z | 2008 | Lancet In- fect Dis2008，8，1： | 1 |
| 17 | Comparison ofPubMed,Scopus, Web of Science, and Google Scholar: Strengthsand weaknesses 显示文摘 | Falagas M E Pitsouni E I Malietzis G A | 2008 | The FASEB Journal2008，22，2： | 1 |
| 18 | Pandrug-resistant Gram-negativebacteria: the dawn of the post-antibioric era显示文摘 | Falagas M E Bliziotis I A | 2007 | Int JAntimicrob Agents2007，29，6： | 1 |
| 19 | Fosfomycin for the treatment of multidrug-resistant,including extended-spectrum beta-lactamase producing,Enterobacteriaceae infections:a systematic review显示文摘 | Falagas M E Kastoris A C Kapaskelis A M | 2010 | Lancet Infect Dis2010，10，1： | 1 |
| 20 | Effect ofmeteorological variables on the incidence of respiratory tract infections显示文摘 | FALAGAS M E THEOCHARIS G SPANOS A | 2008 | Respir Med2008，102，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员